Study on Anemia Risk and Oral Iron Treatment in Women Aged 18 to 55 With Non-Anemic Iron Deficiency

What this Trial Is About

Researchers are studying women aged 18 to 55 years who have non-anemic iron deficiency to understand the risk of developing anemia and to evaluate the effects of oral iron therapy. The study aims to identify early signs that predict anemia progression and to assess how dietary changes and iron treatment impact symptoms and blood test results. This research focuses on individual factors related to iron deficiency and its management. Participants first undergo a two-month nutritional intervention where they receive counseling to increase iron intake and absorption through diet. After this phase, blood tests categorize participants into groups based on their iron status. Those with persistent iron deficiency then receive a daily oral dose of 80 mg elemental iron ferrous sulfate for one month. Adherence and symptoms are monitored regularly by phone and clinic visits throughout both phases. During the study, participants complete symptom questionnaires and have blood tests to measure hemoglobin, ferritin, iron levels, and inflammatory markers at the start, after the nutritional phase, and following the iron therapy. Researchers track changes in symptoms and laboratory values to evaluate the effects of the interventions. The total study period includes two months of diet counseling and one month of oral iron treatment, with ongoing monitoring to assess safety and response.

Risk of Anemia and Effects of Oral Iron Therapy in Non-Anemic Iron-Deficient Women (18-55 Years)